Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7681 AL 7695

Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration

Hussain MS, Agrawal N, Ilma B, M M R, Nayak PP, Kaur M, Khachi A, Goyal K, Rekha A, Gupta S, Gupta G, Dua K.

CNS Neurosci Ther. 2025 Jul;31(7):e70503. doi: 10.1111/cns.70503.

Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities

Yu Q, Li L, Yu S, Han J, Cheng Q, Cui Z, Chen H, Li M, Lu Z.

Neurochem Res. 2025 Jul 28;50(4):251. doi: 10.1007/s11064-025-04490-z.

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer's Disease

Asim A, Jastrzębski MK, Kaczor AA.

Molecules. 2025 Jul 15;30(14):2975. doi: 10.3390/molecules30142975.

The potential of acupuncture in the treatment of Alzheimer's disease: An exploration from traditional Chinese medicine to modern technology

Wang M, Zhang L, Huang W, Huang J, Luo Y, Huang N.

Complement Ther Med. 2025 Oct;93:103222. doi: 10.1016/j.ctim.2025.103222. Epub 2025 Jul 30.

A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies

Hering H, Bussiere T, Liu CC, Glajch KE, Weihofen A, Grogan J, Walsh DM.

Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.

Histone Deacetylase 2 in Alzheimer's Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting

Asadi K, K R, Satarker S, Gurram PC.

Mol Neurobiol. 2025 Dec;62(12):16489-16511. doi: 10.1007/s12035-025-05264-y. Epub 2025 Aug 8.

Resveratrol as a Therapeutic Agent in Alzheimer's Disease: Evidence from Clinical Studies

Puranik N, Kumari M, Tiwari S, Dhakal T, Song M.

Nutrients. 2025 Aug 5;17(15):2557. doi: 10.3390/nu17152557.

A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease

Bragais EK, Luna KLD, Timoteo-Garcia VJ.

Biol Trace Elem Res. 2026 Mar;204(3):1848-1865. doi: 10.1007/s12011-025-04788-7. Epub 2025 Aug 14.

Revisiting APOE: Insights from rare variants and the expanding landscape of Alzheimer's disease genetics

Gim J.

J Alzheimers Dis. 2025 Oct;107(4):1409-1410. doi: 10.1177/13872877251366662. Epub 2025 Aug 17.

[Donanemab, an Amyloid β-targeting Antibody for Early Symptomatic Alzheimer's Disease: Summary of Clinical Study Results]

Sato S, Iwata A, Ishii K, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Aug;77(8):907-920. doi: 10.11477/mf.188160960770080907.

Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease

Wasim R.

Inflammopharmacology. 2025 Sep;33(9):5273-5289. doi: 10.1007/s10787-025-01916-6. Epub 2025 Aug 27.

Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer's Disease

Koga-Batko J, Antosz-Popiołek K, Nowakowska H, Błażejewska M, Kowalik EM, Beszłej JA, Leszek J.

Int J Mol Sci. 2025 Aug 10;26(16):7725. doi: 10.3390/ijms26167725.

Honey as a Neuroprotective Agent: Molecular Perspectives on Its Role in Alzheimer's Disease

Navarro-Hortal MD, Romero-Márquez JM, Ansary J, Hinojosa-Nogueira D, Montalbán-Hernández C, Varela-López A, Quiles JL.

Nutrients. 2025 Aug 8;17(16):2577. doi: 10.3390/nu17162577.

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid-β, Oxidative Stress, and Neuroinflammation

Zamanian MY, Khachatryan LG, Heidari M, Darabi R, Golmohammadi M, Al-Aouadi RFA, Akkol EK.

Biofactors. 2025 Sep-Oct;51(5):e70047. doi: 10.1002/biof.70047.

Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments

Liu G, Sun Y.

J Alzheimers Dis. 2025 Oct;107(4):1374-1399. doi: 10.1177/13872877251374149. Epub 2025 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias